Clinical Trial Update: A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease [Phase 2]

View source ↗

Summary

This Phase 2 trial update describes evaluating BIO 300 with thoracic radiation therapy in people with non-small cell lung cancer and interstitial lung disease; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Interstitial Lung Disease Due to Connective Tissue Disease
• Non-small Cell Lung Cancer

Drugs mentioned

• BIO 300

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: NSCLC, NSCLC, Stage I | Phase 2 | Status: RECRUITING